Literature DB >> 29025421

Correction to: Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples.

Dagmara W Lewandowska1, Osvaldo Zagordi1, Fabienne-Desirée Geissberger1, Verena Kufner1, Stefan Schmutz1, Jürg Böni1, Karin J Metzner1,2, Alexandra Trkola1, Michael Huber3.   

Abstract

Entities:  

Year:  2017        PMID: 29025421      PMCID: PMC5637349          DOI: 10.1186/s40168-017-0351-x

Source DB:  PubMed          Journal:  Microbiome        ISSN: 2049-2618            Impact factor:   14.650


× No keyword cloud information.

Correction

Following publication of the original article [1], the authors were alerted by a colleague of a column duplication in Table 1. Since the summary row was correct, though, the interpretation and the conclusion of the article were not affected.
Table 1:

Number of reads reported from sequencing a multiplexed viral pathogen reagent

Replicate 1Replicate 2
Virus species (most frequent strain)all 3'505'318 reads2'000'000 reads150'000 readsall 2'676'604 reads2'000'000 reads150'000 reads
25 target viruses
 Human astrovirus (Human astrovirus 1)27'62215’783.21’184.110'7818’040.6596.2
 Enterovirus B (Human coxsackievirus B4)27'25215’539.01’161.330'40922’707.31’704.4
 Human herpesvirus 16739.03.510681.45.5
 Human herpesvirus 221.30.497.00.4
 Human herpesvirus 3 (Human herpesvirus 3 strain Dumas)3417.41.410584.26.4
 Human herpesvirus 416698.18.2149104.78.7
 Human herpesvirus 58'3274’743.1352.19'3987’028.5524.4
 Human mastadenovirus C (Human adenovirus 2)2311.50.8404299.119.6
 Human mastadenovirus F (Human adenovirus 41)22.00.01913.91.7
 Human metapneumovirus00.00.000.00.0
 Human parainfluenza virus 121'38712’170.8921.212'8979’601.2718.6
 Human parainfluenza virus 22'8791651.5119.64433.11.6
 Human parainfluenza virus 300.00.000.00.0
 Human parainfluenza virus 4 (Human parainfluenzavirus 4b)21'85812’478.6924.313'45610’089.8760.2
 Human respiratory syncytial virus00.00.0298229.415.5
 Human Rhinovirus A (Human rhinovirus A39)00.00.02'9832’238.4158.6
 Influenzavirus A H1N100.00.000.00.0
 Parechovirus A (Human parechovirus 3)1'492'756851’560.663862.7756'598565’228.542’434.5
 Rotavirus A62.80.3128.50.8
 Sapporovirus (Sapovirus Hu/GI.2/BR-DF01/BRA/2009 and Hu/G1/BE-HPI01/DE/2012)1'019575.545.28262.85.1
 Human coronavirus 229E00.00.000.00.0
 Norovirus GI00.00.000.00.0
 Norovirus GII00.00.000.00.0
 Influenza virus B00.00.000.00.0
 Influenza virus A H3N200.00.000.00.0
Non-target viruses
 Bovine viral diarrhea virus 11'446820.663.62'5261’891.8140.3
 Bovine viral diarrhea virus 210.40.400.00.0
 Primate bocaparvovirus 100.00.000.00.0
 Primate bocaparvovirus 2208118.27.511791.66.8
 Human enterovirus (Enterovirus CA55-1988)3'1991’834.7140.6495380.628.7
 Aichi virus00.00.000.00.0
 Ungulate bocaparvovirus 100.00.000.00.0
 Porcine/other circovirus00.00.000.00.0
Total virus reads1'608'254917'448.368'797.2840'888628'222.447'138.0
Number of detected target viruses1514.411.71717.015.7

For subsamples of reads the average number of virus reads and detected target viruses in 10 random samplings is shown

Number of reads reported from sequencing a multiplexed viral pathogen reagent For subsamples of reads the average number of virus reads and detected target viruses in 10 random samplings is shown
  1 in total

1.  Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples.

Authors:  Dagmara W Lewandowska; Osvaldo Zagordi; Fabienne-Desirée Geissberger; Verena Kufner; Stefan Schmutz; Jürg Böni; Karin J Metzner; Alexandra Trkola; Michael Huber
Journal:  Microbiome       Date:  2017-08-08       Impact factor: 14.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.